Kdo2-Lipid A / ATP gene array data - treatment:control ratiosKEGG pathway: Taste transduction (mmu04742)Legend: | : View data/graphs for replicates |
---|
|
Gene symbol   |
Time course plot |
Accession |
Description |
Treatment |
15min |
30min |
1hr |
2hr |
4hr |
8hr |
20hr |
Accn1 | |
BC038551 |
amiloride-sensitive cation channel 1, neuronal (degenerin), mRNA (cDNA clone IMAGE:5119213), complete cds. [BC038551] |
KLA | 1.04 |
1.07 |
1.02 |
1.00 |
.98 |
1.02 |
.98 |
| ATP | 1.08 |
.97 |
.97 |
.97 |
1.01 |
1.07 |
1.02 |
| KLA/ATP | 1.05 |
.95 |
1.00 |
1.07 |
.97 |
.99 |
1.02 |
|
Accn1 | |
NM_007384 |
amiloride-sensitive cation channel 1, neuronal (degenerin) (Accn1), transcript variant 1, mRNA [NM_007384] |
KLA | 1.00 |
.99 |
1.05 |
.98 |
1.00 |
1.07 |
1.07 |
| ATP | 1.00 |
.98 |
1.02 |
1.02 |
1.01 |
.99 |
.97 |
| KLA/ATP | 1.01 |
.99 |
1.04 |
1.02 |
1.00 |
.94 |
.96 |
|
Adcy4 | |
NM_080435 |
adenylate cyclase 4 (Adcy4), mRNA [NM_080435] |
KLA | 1.05 |
1.07 |
.96 |
1.00 |
1.04 |
1.05 |
1.05 |
| ATP | 1.02 |
1.05 |
1.02 |
1.48 |
1.37 |
1.08 |
1.09 |
| KLA/ATP | 1.00 |
1.05 |
.91 |
1.19 |
1.35 |
1.27 |
1.08 |
|
Adcy6 | |
NM_007405 |
adenylate cyclase 6 (Adcy6), mRNA [NM_007405] |
KLA | 1.10 |
1.16 |
1.16 |
1.09 |
1.08 |
1.06 |
.99 |
| ATP | 1.05 |
.97 |
1.08 |
1.12 |
1.08 |
1.08 |
1.04 |
| KLA/ATP | 1.14 |
1.20 |
1.29 |
1.30 |
1.25 |
1.11 |
1.07 |
|
Adcy8 | |
NM_009623 |
adenylate cyclase 8 (Adcy8), mRNA [NM_009623] |
KLA | 1.00 |
1.00 |
1.07 |
.97 |
1.04 |
.98 |
1.02 |
| ATP | 1.04 |
1.05 |
1.14 |
1.03 |
.99 |
1.00 |
.97 |
| KLA/ATP | 1.05 |
1.04 |
1.00 |
1.03 |
.98 |
.94 |
.96 |
|
Cacna1a | |
NM_007578 |
calcium channel, voltage-dependent, P/Q type, alpha 1A subunit (Cacna1a), mRNA [NM_007578] |
KLA | .71 |
.66 |
.61 |
.63 |
.60 |
.71 |
.72 |
| ATP | 1.07 |
1.04 |
.89 |
1.08 |
.71 |
.56 |
.75 |
| KLA/ATP | .71 |
.72 |
.85 |
.69 |
.64 |
.63 |
.68 |
|
Cacna1b | |
U04999 |
N-type calcium channel alpha1 subunit mRNA, complete cds [U04999] |
KLA | .94 |
.94 |
.95 |
.88 |
1.09 |
.85 |
.92 |
| ATP | 1.06 |
1.17 |
1.00 |
1.24 |
1.59 |
1.15 |
1.17 |
| KLA/ATP | .91 |
.91 |
.95 |
.95 |
.90 |
.97 |
1.01 |
|
Gnas | |
AF107847 |
neuroendocrine-specific Golgi protein p55 isoform 1 (XLalphas) alternatively spliced mRNA, complete cds. [AF107847] |
KLA | 1.04 |
.94 |
1.00 |
1.05 |
1.04 |
.98 |
1.00 |
| ATP | .98 |
.97 |
.96 |
1.00 |
.99 |
.98 |
1.02 |
| KLA/ATP | 1.04 |
1.02 |
.96 |
.95 |
1.01 |
.96 |
1.01 |
|
Gnas | |
AK017423 |
10 days neonate head cDNA, RIKEN full-length enriched library, clone:5530400H20 product:novel noncoding RNA overlapping the exon 1A, 1 and 2 of Gnas, full insert sequence. [AK017423] |
KLA | .85 |
1.08 |
.97 |
.92 |
1.05 |
1.03 |
1.08 |
| ATP | .99 |
1.30 |
2.11 |
1.73 |
1.23 |
1.01 |
1.02 |
| KLA/ATP | .96 |
1.06 |
1.58 |
1.34 |
1.29 |
1.05 |
.91 |
|
Gnas | |
NM_001077510 |
GNAS (guanine nucleotide binding protein, alpha stimulating) complex locus (Gnas), transcript variant 8, mRNA [NM_001077510] |
KLA | .99 |
1.03 |
.97 |
.91 |
1.03 |
.95 |
.97 |
| ATP | 1.04 |
1.19 |
1.15 |
1.61 |
1.24 |
.91 |
1.00 |
| KLA/ATP | 1.06 |
.97 |
1.01 |
1.46 |
1.04 |
.85 |
1.01 |
|
Gnas | |
S49980 |
gb|stimulatory G protein alpha subunit {clone WC-16} [mice, whole cochlea, mRNA Partial, 356 nt]. [S49980] |
KLA | .91 |
.88 |
1.03 |
.87 |
.90 |
.84 |
1.01 |
| ATP | 1.16 |
1.22 |
1.02 |
1.55 |
1.16 |
.80 |
.99 |
| KLA/ATP | 1.01 |
1.13 |
.86 |
1.12 |
.97 |
.85 |
1.08 |
|
Gnb1 | |
NM_008142 |
guanine nucleotide binding protein (G protein), beta 1 (Gnb1), mRNA [NM_008142] |
KLA | 1.11 |
1.18 |
1.22 |
1.19 |
1.29 |
1.32 |
1.76 |
| ATP | 1.02 |
1.09 |
.84 |
.99 |
.97 |
.89 |
1.22 |
| KLA/ATP | 1.20 |
1.25 |
.85 |
1.01 |
.86 |
.91 |
1.57 |
|
Gnb3 | |
NM_013530 |
guanine nucleotide binding protein (G protein), beta 3 (Gnb3), mRNA [NM_013530] |
KLA | .99 |
1.00 |
.98 |
1.03 |
.94 |
.99 |
.96 |
| ATP | 1.01 |
1.02 |
.97 |
.95 |
1.01 |
.97 |
.92 |
| KLA/ATP | .99 |
1.02 |
1.02 |
.98 |
.99 |
.85 |
.99 |
|
Gng13 | |
NM_022422 |
guanine nucleotide binding protein (G protein), gamma 13 (Gng13), mRNA [NM_022422] |
KLA | 1.04 |
1.04 |
.94 |
1.00 |
1.00 |
1.05 |
.96 |
| ATP | 1.07 |
1.05 |
1.02 |
.94 |
.98 |
1.03 |
1.01 |
| KLA/ATP | 1.01 |
.99 |
1.05 |
1.01 |
1.01 |
.98 |
1.02 |
|
Gng3 | |
NM_010316 |
guanine nucleotide binding protein (G protein), gamma 3 (Gng3), mRNA [NM_010316] |
KLA | 1.00 |
.98 |
1.02 |
.95 |
.99 |
1.00 |
1.06 |
| ATP | .98 |
1.05 |
.99 |
1.03 |
1.05 |
1.03 |
.97 |
| KLA/ATP | 1.01 |
1.00 |
1.07 |
1.01 |
1.04 |
1.04 |
1.05 |
|
Grm4 | |
NM_001013385 |
glutamate receptor, metabotropic 4 (Grm4), mRNA [NM_001013385] |
KLA | .94 |
.97 |
.98 |
1.01 |
1.01 |
1.02 |
1.08 |
| ATP | .99 |
.94 |
1.03 |
.98 |
.95 |
.98 |
1.07 |
| KLA/ATP | .99 |
1.02 |
.93 |
1.00 |
1.02 |
1.03 |
1.05 |
|
Itpr3 | |
NM_080553 |
inositol 1,4,5-triphosphate receptor 3 (Itpr3), mRNA [NM_080553] |
KLA | .55 |
.51 |
.45 |
.41 |
.34 |
.34 |
.45 |
| ATP | 1.01 |
.92 |
1.02 |
.57 |
.46 |
.34 |
1.22 |
| KLA/ATP | .56 |
.48 |
.48 |
.29 |
.33 |
.27 |
.65 |
|
Kcnb1 | |
NM_008420 |
potassium voltage gated channel, Shab-related subfamily, member 1 (Kcnb1), mRNA [NM_008420] |
KLA | .98 |
.99 |
.96 |
1.01 |
1.02 |
1.02 |
1.04 |
| ATP | .97 |
1.01 |
.98 |
1.02 |
.99 |
1.00 |
1.02 |
| KLA/ATP | .96 |
.99 |
.97 |
1.00 |
1.01 |
.99 |
.98 |
|
Mm.28666 8 | |
148271108 |
Unknown |
KLA | 1.06 |
1.03 |
1.02 |
1.00 |
.98 |
.97 |
.96 |
| ATP | 1.04 |
1.07 |
.98 |
1.01 |
1.05 |
1.04 |
.97 |
| KLA/ATP | 1.06 |
1.04 |
.98 |
1.08 |
1.01 |
1.02 |
.98 |
|
Mm.4424 | |
110225367 |
Unknown |
KLA | .99 |
.93 |
1.01 |
1.02 |
1.00 |
.92 |
1.00 |
| ATP | .98 |
1.03 |
3.11 |
1.13 |
1.19 |
1.03 |
1.11 |
| KLA/ATP | .95 |
.97 |
.97 |
.96 |
.93 |
1.01 |
.99 |
|
Pde1a | |
NM_001009978 |
phosphodiesterase 1A, calmodulin-dependent (Pde1a), transcript variant 7, mRNA [NM_001009978] |
KLA | 1.42 |
1.46 |
1.58 |
1.35 |
1.43 |
1.21 |
1.25 |
| ATP | 1.02 |
1.01 |
1.07 |
1.13 |
1.50 |
1.46 |
1.08 |
| KLA/ATP | 1.44 |
1.52 |
1.27 |
1.38 |
1.23 |
1.40 |
1.41 |
|
Pde1a | |
NM_016744 |
phosphodiesterase 1A, calmodulin-dependent (Pde1a), mRNA [NM_016744] |
KLA | .98 |
.99 |
1.03 |
1.04 |
1.02 |
.96 |
1.04 |
| ATP | 1.02 |
1.02 |
1.05 |
1.03 |
1.00 |
.98 |
.98 |
| KLA/ATP | .99 |
1.00 |
1.08 |
1.03 |
1.01 |
1.04 |
1.00 |
|
Plcb2 | |
NM_177568 |
phospholipase C, beta 2 (Plcb2), mRNA [NM_177568] |
KLA | .70 |
.68 |
.64 |
.67 |
.65 |
.76 |
.88 |
| ATP | .95 |
.94 |
1.04 |
.94 |
.72 |
.57 |
1.19 |
| KLA/ATP | .69 |
.68 |
.72 |
.63 |
.65 |
.55 |
.70 |
|
Prkaca | |
NM_008854 |
protein kinase, cAMP dependent, catalytic, alpha (Prkaca), mRNA [NM_008854] |
KLA | .71 |
.74 |
.72 |
.70 |
.72 |
.84 |
.85 |
| ATP | 1.05 |
.98 |
.89 |
.92 |
.76 |
.60 |
1.02 |
| KLA/ATP | .79 |
.74 |
.55 |
.65 |
.60 |
.65 |
.93 |
|
Prkacb | |
NM_011100 |
protein kinase, cAMP dependent, catalytic, beta (Prkacb), mRNA [NM_011100] |
KLA | .69 |
.70 |
.66 |
.58 |
.51 |
.55 |
.59 |
| ATP | 1.02 |
1.19 |
.97 |
1.01 |
.69 |
.38 |
.56 |
| KLA/ATP | .72 |
.73 |
.57 |
.62 |
.47 |
.41 |
.45 |
|
Prkx | |
NM_016979 |
protein kinase, X-linked (Prkx), mRNA [NM_016979] |
KLA | 3.61 |
3.79 |
4.67 |
4.66 |
4.85 |
4.19 |
1.43 |
| ATP | .98 |
.90 |
.63 |
.61 |
1.12 |
1.90 |
1.29 |
| KLA/ATP | 3.56 |
3.36 |
2.62 |
2.06 |
2.26 |
2.87 |
2.31 |
|
Scnn1a | |
NM_011324 |
sodium channel, nonvoltage-gated, type I, alpha (Scnn1a), mRNA [NM_011324] |
KLA | .86 |
.87 |
.83 |
.83 |
.84 |
.95 |
1.22 |
| ATP | 1.03 |
.97 |
.91 |
.90 |
.81 |
.73 |
.87 |
| KLA/ATP | .88 |
.85 |
.87 |
.76 |
.77 |
.76 |
.81 |
|
Scnn1b | |
NM_011325 |
sodium channel, nonvoltage-gated 1 beta (Scnn1b), mRNA [NM_011325] |
KLA | 1.00 |
.99 |
1.05 |
1.04 |
.98 |
1.01 |
1.11 |
| ATP | 1.00 |
.99 |
.93 |
1.03 |
1.04 |
.96 |
.96 |
| KLA/ATP | .98 |
1.03 |
.94 |
.97 |
.97 |
1.01 |
.86 |
|
Scnn1g | |
NM_011326 |
sodium channel, nonvoltage-gated 1 gamma (Scnn1g), mRNA [NM_011326] |
KLA | .97 |
.98 |
1.05 |
1.04 |
1.00 |
1.00 |
.96 |
| ATP | 1.04 |
.99 |
.99 |
1.01 |
.98 |
1.04 |
.95 |
| KLA/ATP | .94 |
.96 |
.99 |
.94 |
.99 |
1.00 |
1.02 |
|
Tas1r1 | |
NM_031867 |
taste receptor, type 1, member 1 (Tas1r1), mRNA [NM_031867] |
KLA | .99 |
1.06 |
1.03 |
1.14 |
1.01 |
1.00 |
1.06 |
| ATP | 1.00 |
.98 |
1.03 |
.98 |
.99 |
1.03 |
.89 |
| KLA/ATP | .98 |
1.02 |
1.09 |
.97 |
1.01 |
1.00 |
1.09 |
|
Tas1r2 | |
NM_031873 |
taste receptor, type 1, member 2 (Tas1r2), mRNA [NM_031873] |
KLA | .98 |
.97 |
1.09 |
1.07 |
1.04 |
1.07 |
1.11 |
| ATP | .96 |
1.00 |
1.06 |
2.63 |
2.51 |
1.41 |
1.19 |
| KLA/ATP | 1.02 |
1.08 |
1.11 |
2.55 |
2.91 |
1.76 |
1.13 |
|
Tas1r3 | |
NM_031872 |
taste receptor, type 1, member 3 (Tas1r3), mRNA [NM_031872] |
KLA | 1.11 |
1.20 |
1.23 |
1.21 |
1.17 |
1.44 |
1.13 |
| ATP | 1.05 |
1.07 |
1.09 |
1.20 |
1.07 |
1.05 |
1.14 |
| KLA/ATP | 1.18 |
1.18 |
1.03 |
1.19 |
1.18 |
1.10 |
1.25 |
|
Tas2r102
| |
NM_199153 |
taste receptor, type 2, member 102 (Tas2r102), mRNA [NM_199153] |
KLA | .95 |
.99 |
1.06 |
1.04 |
.99 |
.97 |
1.03 |
| ATP | .94 |
1.02 |
1.01 |
1.00 |
1.05 |
1.03 |
.98 |
| KLA/ATP | .99 |
1.00 |
.97 |
.89 |
1.04 |
1.01 |
.90 |
|
Tas2r105
| |
NM_020501 |
taste receptor, type 2, member 105 (Tas2r105), mRNA [NM_020501] |
KLA | .97 |
.99 |
.99 |
1.04 |
.92 |
1.00 |
.94 |
| ATP | 1.04 |
.99 |
.97 |
.99 |
.99 |
.98 |
1.04 |
| KLA/ATP | .98 |
1.02 |
1.01 |
1.00 |
.92 |
.97 |
.98 |
|
Tas2r107
| |
NM_199154 |
taste receptor, type 2, member 107 (Tas2r107), mRNA [NM_199154] |
KLA | .96 |
1.06 |
1.00 |
1.03 |
.89 |
.97 |
.96 |
| ATP | 1.05 |
1.04 |
.93 |
.94 |
.93 |
.97 |
1.01 |
| KLA/ATP | 1.00 |
.96 |
.98 |
.96 |
.99 |
.93 |
.98 |
|
Tas2r108
| |
NM_020502 |
taste receptor, type 2, member 108 (Tas2r108), mRNA [NM_020502] |
KLA | .95 |
.99 |
.93 |
.95 |
.96 |
1.05 |
.99 |
| ATP | 1.01 |
1.01 |
1.07 |
1.05 |
1.01 |
.91 |
1.06 |
| KLA/ATP | 1.03 |
.99 |
1.01 |
.97 |
1.00 |
1.07 |
1.02 |
|
Tas2r110
| |
NM_199155 |
taste receptor, type 2, member 110 (Tas2r110), mRNA [NM_199155] |
KLA | .96 |
1.01 |
1.02 |
.98 |
1.01 |
1.00 |
.96 |
| ATP | 1.00 |
1.00 |
.99 |
.92 |
1.01 |
1.03 |
1.02 |
| KLA/ATP | .97 |
1.04 |
1.03 |
.98 |
.96 |
1.00 |
.97 |
|
Tas2r116
| |
NM_053212 |
taste receptor, type 2, member 116 (Tas2r116), mRNA [NM_053212] |
KLA | .96 |
.97 |
1.01 |
.96 |
1.03 |
.91 |
1.05 |
| ATP | .99 |
.97 |
.94 |
1.05 |
.98 |
1.03 |
.98 |
| KLA/ATP | .97 |
1.01 |
.86 |
.95 |
.99 |
1.05 |
.95 |
|
Tas2r118
| |
NM_207022 |
taste receptor, type 2, member 118 (Tas2r118), mRNA [NM_207022] |
KLA | 1.03 |
1.02 |
1.00 |
.96 |
.99 |
1.04 |
.96 |
| ATP | .98 |
1.06 |
1.17 |
1.03 |
.96 |
1.02 |
1.01 |
| KLA/ATP | 1.00 |
.93 |
1.08 |
1.02 |
.92 |
.93 |
.97 |
|
Tas2r119
| |
NM_020503 |
taste receptor, type 2, member 119 (Tas2r119), mRNA [NM_020503] |
KLA | 1.02 |
1.01 |
1.00 |
1.04 |
.98 |
.99 |
1.15 |
| ATP | 1.02 |
1.01 |
.98 |
1.03 |
1.02 |
1.00 |
.96 |
| KLA/ATP | .99 |
1.01 |
1.00 |
.99 |
.99 |
.99 |
1.03 |
|
Tas2r130
| |
NM_199156 |
taste receptor, type 2, member 130 (Tas2r130), mRNA [NM_199156] |
KLA | 1.01 |
.97 |
.99 |
1.00 |
1.04 |
1.04 |
1.00 |
| ATP | 1.00 |
.96 |
1.01 |
1.03 |
1.00 |
.98 |
.96 |
| KLA/ATP | .93 |
.93 |
1.00 |
1.08 |
1.08 |
1.05 |
1.07 |
|
Tas2r135
| |
NM_199159 |
taste receptor, type 2, member 135 (Tas2r135), mRNA [NM_199159] |
KLA | 1.04 |
1.03 |
.99 |
.99 |
.94 |
1.03 |
.97 |
| ATP | 1.00 |
.98 |
1.07 |
1.06 |
1.00 |
1.05 |
1.03 |
| KLA/ATP | 1.02 |
.94 |
.99 |
1.09 |
1.01 |
1.00 |
1.05 |
|
Tas2r136
| |
NM_181276 |
taste receptor, type 2, member 136 (Tas2r136), mRNA [NM_181276] |
KLA | .99 |
.96 |
1.02 |
1.06 |
1.00 |
1.00 |
1.04 |
| ATP | .99 |
1.00 |
.94 |
1.03 |
1.01 |
1.02 |
1.04 |
| KLA/ATP | .98 |
1.02 |
1.02 |
.99 |
1.01 |
.97 |
1.07 |
|
Tas2r139
| |
NM_181275 |
taste receptor, type 2, member 139 (Tas2r139), mRNA [NM_181275] |
KLA | 1.09 |
.94 |
1.02 |
.98 |
1.07 |
1.07 |
.97 |
| ATP | .98 |
.95 |
1.00 |
1.01 |
1.12 |
.98 |
1.03 |
| KLA/ATP | .90 |
.97 |
1.03 |
1.00 |
1.02 |
1.00 |
1.03 |
|
Tas2r140
| |
NM_021562 |
taste receptor, type 2, member 140 (Tas2r140), mRNA [NM_021562] |
KLA | .98 |
1.03 |
.99 |
.95 |
.98 |
.99 |
.96 |
| ATP | 1.02 |
1.01 |
.95 |
.90 |
.93 |
.92 |
.98 |
| KLA/ATP | .95 |
1.02 |
1.02 |
.95 |
.94 |
.89 |
1.01 |
|
Trpm5 | |
NM_020277 |
transient receptor potential cation channel, subfamily M, member 5 (Trpm5), mRNA [NM_020277] |
KLA | 1.02 |
1.01 |
.98 |
1.02 |
.99 |
.96 |
1.03 |
| ATP | .98 |
.94 |
.93 |
.93 |
1.06 |
.90 |
.98 |
| KLA/ATP | 1.06 |
1.04 |
1.02 |
.99 |
1.03 |
1.04 |
1.05 |
|
|